Recent Confirmations include:

Gennady Godovalnikov, Deputy Minister, Director of the Department of Pharmaceutical Industry, Ministry of Health, Republic of Belarus

Mirzanazim Dusmuratov, Chairman of the Board, The State – Joint Stock Сoncern “Uzpharmsanoat”

Ismatzhon Azizov, Deputy Head, Department of the Quality Control of Drugs and Medical Devices, Ministry of Health of the Republic of Uzbekistan

Botagoz Smagulova, Acting Head of Pharmaceutical Activity, Quality, Medicines Usage Control Department,  Medical and Pharmaceutical Activity Control Committee,  Ministry of Health of the Republic of Kazakhstan

• REGULATION OF CIS PHARMA MARKETS: Government programmes and legislative framework

  What were the results in 2011 and what can market players expect from regulatory bodies in the near future? In this session you can learn what the government's current priorities are, and what plans are in place to  develop the pharmaceuticak sector in CIS. You will also be able to discuss recent and planned changes to the industry's regulatory policy with representatives of government structures and key figures from the pharmaceutical sector.

• LEADERS’ STRATEGIES: Strategic planning, commercial decisions and business models

  Senior professionals from the CIS’s leading pharmaceutical companies will discuss the sector’s hottest topics. Regional directors and local market leaders will share their views on possible scenarios for sector development and issues that could stand in the way of businesses in the coming years, and will also analyse the most important  elements to successful strategic development. Followed by the discussion; How to maintane stable business development and overcome external challenges?

• Future Development of THE CUSTOMS UNION & SINGLE ECONOMIC UNION 

  This session will offer an in-depth analysis of recent initiatives by the Commission of the Customs Union, and a discussion of the related problems, with an evaluation of how to solve them.

• ON-STAGE INTERVIEW with Luiza Nocun, Vice-President, Commercial Director, Chimpharm

  During this informal discussion, Ms. Nocun will speak about how companies have successfully implemented strategies in CIS countries (including the purchase of a local producer in the Republic of Kazakhstan), and will share her opinions on existing problems and opportunities for further sector development. 

• Analysis of the Attractiveness to Investors of CIS Pharma Projects

  This session will be dedicated to analysis of the current situation on CIS pharmaceutical markets, existing possibilities for strategic purchases, investments into production and joint ventures. Its discussions will include forecasts and new strategic analysis of the investment climate in the pharmaceutical markets of CIS countries.

• In-Depth Focus! MARKET ACCESS in the CIS region

• THE FUTURE OF GMP:  Is sector transformation on the right track?

  Which preliminary conclusions can be made about the possibility of using government programmes to bring pharmaceutical production in the CIS up to speed with GMP standards, and what input is necessary from the government to stimulate this process?

• Networking Opportunities!

  The networking opportunities start well before the Forum opens, and continue long after it ends. As a pioneer of the use of social media in our events we provide an easy way for industry executives to communicate, collaborate and create a focused community: our online networking platform E-CONNECT.

  The CIS PHARMACEUTICAL FORUM will also feature audience Q&A slots within each session, networking breaks, evening receptions and many other ways for you to establish new business contacts.

• View CIS Pharmaceutical Forum programme here